Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
By S. Rapp, Mark A. Espeland, S. Shumaker, V. Henderson, R. Brunner, JoAnn E. Manson, M. Gass, M. Stefanick, D. Lane, J. Hays and 4 more. Journal of the American Medical Association (JAMA), 2003
954 citations recorded by the source corpus.
Subfields: Endocrinology, Diabetes and Metabolism, Psychiatry and Mental health, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/7e507ff0541d69a99ca1a109571b08e58be751be
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Endocrinology, Diabetes and Metabolism
In Pulmonary and Respiratory Medicine
Citations in the corpus
- Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. (2004, methodology): “These exclusions were also applied to reanalyses of the estrogen plus progestin trial data, eliminating 37 women who were included in our earlier study.(16)”
- Single-Sex Education and the Brain (2013, result): “Again, some studies looked very promising (reviewed in Sherwin 2003), but subsequent research, including the very large, NIH-sponsored Women’s Health Initiative Memory Study (WHIMS), found either no benefit or, in the case of WHIMS, actually increased risk of dementia and cognitive decline with horm”
- Sex Differences in Cognitive Functions (2009, background): “The negative effects of HT on cognitive performance found by Women’s Health Initiative (Rapp et al., 2003) have invoked uncertainty and fear against HT.”
- Sex hormones affect neurotransmitters and shape the adult female brain during hormonal transition periods (2015, background): “In general, positive (Hogervorst et al., 2000; LeBlanc et al., 2001; Rice and Morse, 2003; Weber et al., 2014) and negative (Rapp et al., 2003; Shumaker et al., 2003) effects on cognition have been reported for HRT.”
- Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. (2003, methodology): “Most research on hormone therapy andcognitionofpostmenopausalwomen evaluates cognitive function, not dementia.(35) The less extensive research on the possible role of hormone therapy for the prevention of dementia is primarily observational and focuses on AD as opposed to all-cause dementia.”